319 related articles for article (PubMed ID: 27925693)
21. Rhodomyrtosone B, a membrane-targeting anti-MRSA natural acylgphloroglucinol from Rhodomyrtus tomentosa.
Zhao LY; Liu HX; Wang L; Xu ZF; Tan HB; Qiu SX
J Ethnopharmacol; 2019 Jan; 228():50-57. PubMed ID: 30195566
[TBL] [Abstract][Full Text] [Related]
22. Influence of subinhibitory concentrations of NH125 on biofilm formation & virulence factors of Staphylococcus aureus.
Liu Q; Zheng Z; Kim W; Burgwyn Fuchs B; Mylonakis E
Future Med Chem; 2018 Jun; 10(11):1319-1331. PubMed ID: 29846088
[TBL] [Abstract][Full Text] [Related]
23. Stimulated phase-shift acoustic nanodroplets enhance vancomycin efficacy against methicillin-resistant
Guo H; Wang Z; Du Q; Li P; Wang Z; Wang A
Int J Nanomedicine; 2017; 12():4679-4690. PubMed ID: 28721044
[TBL] [Abstract][Full Text] [Related]
24. Discovery of quinoline small molecules with potent dispersal activity against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis biofilms using a scaffold hopping strategy.
Abouelhassan Y; Garrison AT; Burch GM; Wong W; Norwood VM; Huigens RW
Bioorg Med Chem Lett; 2014 Nov; 24(21):5076-80. PubMed ID: 25264073
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilms.
Yang S; Hay ID; Cameron DR; Speir M; Cui B; Su F; Peleg AY; Lithgow T; Deighton MA; Qu Y
Sci Rep; 2015 Dec; 5():18578. PubMed ID: 26687035
[TBL] [Abstract][Full Text] [Related]
26. A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using Galleria mellonella model.
Yuan Y; Zai Y; Xi X; Ma C; Wang L; Zhou M; Shaw C; Chen T
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):849-856. PubMed ID: 30802593
[TBL] [Abstract][Full Text] [Related]
27. Neofiscalin A and fiscalin C are potential novel indole alkaloid alternatives for the treatment of multidrug-resistant Gram-positive bacterial infections.
Bessa LJ; Buttachon S; Dethoup T; Martins R; Vasconcelos V; Kijjoa A; Martins da Costa P
FEMS Microbiol Lett; 2016 Aug; 363(15):. PubMed ID: 27268269
[TBL] [Abstract][Full Text] [Related]
28. In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea.
Cha JO; Park YK; Lee YS; Chung GT
Diagn Microbiol Infect Dis; 2011 May; 70(1):112-8. PubMed ID: 21398072
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of different bioactive glass S53P4 formulations in biofilm eradication and the impact of pH and osmotic pressure.
Müller N; Kollert M; Trampuz A; Gonzalez Moreno M
Colloids Surf B Biointerfaces; 2024 Jul; 239():113940. PubMed ID: 38744081
[TBL] [Abstract][Full Text] [Related]
30. The Path to New Halogenated Quinolines With Enhanced Activities Against
Huigens RW
Microbiol Insights; 2018; 11():1178636118808532. PubMed ID: 30397386
[TBL] [Abstract][Full Text] [Related]
31. Biofilm Antimicrobial Susceptibility Increases With Antimicrobial Exposure Time.
Castaneda P; McLaren A; Tavaziva G; Overstreet D
Clin Orthop Relat Res; 2016 Jul; 474(7):1659-64. PubMed ID: 26797908
[TBL] [Abstract][Full Text] [Related]
32. Remarkable capacity of brosimine b to disrupt methicillin-resistant Staphylococcus aureus (MRSA) preformed biofilms.
Reis SVD; Couto NMG; Brust FR; Trentin DS; Silva JKRD; Arruda MSP; Gnoatto SCB; Macedo AJ
Microb Pathog; 2020 Mar; 140():103967. PubMed ID: 31911193
[TBL] [Abstract][Full Text] [Related]
33. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
[TBL] [Abstract][Full Text] [Related]
34. N-substituted 2-aminoimidazole inhibitors of MRSA biofilm formation accessed through direct 1,3-bis(tert-butoxycarbonyl)guanidine cyclization.
Yeagley AA; Su Z; McCullough KD; Worthington RJ; Melander C
Org Biomol Chem; 2013 Jan; 11(1):130-7. PubMed ID: 23076976
[TBL] [Abstract][Full Text] [Related]
35. Potential of sequential treatment with minocycline and S. aureus specific phage lysin in eradication of MRSA biofilms: an in vitro study.
Chopra S; Harjai K; Chhibber S
Appl Microbiol Biotechnol; 2015 Apr; 99(7):3201-10. PubMed ID: 25707865
[TBL] [Abstract][Full Text] [Related]
36. Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents.
Rogers SA; Huigens RW; Cavanagh J; Melander C
Antimicrob Agents Chemother; 2010 May; 54(5):2112-8. PubMed ID: 20211901
[TBL] [Abstract][Full Text] [Related]
37. Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
Garrison AT; Abouelhassan Y; Norwood VM; Kallifidas D; Bai F; Nguyen MT; Rolfe M; Burch GM; Jin S; Luesch H; Huigens RW
J Med Chem; 2016 Apr; 59(8):3808-25. PubMed ID: 27018907
[TBL] [Abstract][Full Text] [Related]
38. Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent.
Schuch R; Khan BK; Raz A; Rotolo JA; Wittekind M
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461319
[TBL] [Abstract][Full Text] [Related]
39. Novel Miniature Membrane Active Lipopeptidomimetics against Planktonic and Biofilm Embedded Methicillin-Resistant Staphylococcus aureus.
Joshi S; Mumtaz S; Singh J; Pasha S; Mukhopadhyay K
Sci Rep; 2018 Jan; 8(1):1021. PubMed ID: 29348589
[TBL] [Abstract][Full Text] [Related]
40. Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening Strategy.
Kim W; Conery AL; Rajamuthiah R; Fuchs BB; Ausubel FM; Mylonakis E
PLoS One; 2015; 10(6):e0127640. PubMed ID: 26039584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
